Factors increasing severity of peritonitis in long-term peritoneal dialysis patients

Advances in Renal Replacement Therapy

Volumn 5, Issue 3, 1998, Pages 185-193

  Park, M S ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Functional changes; Host defense mechanism; Long term peritoneal dialysis; Peritoneal structural changes; Peritonitis

Indexed keywords

DIALYSIS FLUID;

FIBRIN DEPOSITION; IMMUNE RESPONSE; INFECTION RISK; MESOTHELIUM; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0031878750     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(98)70031-7     Document Type: Article

References (57)

1. SJ Davies J Bryan L Phillip Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis Nephrol Dial Transplant 11 1996 498 506
2. R Maiorca GC Cancarini R Zubani CAPD viability: A longterm comparison with hemodialysis Perit Dial Int 16 1996 276 287
3. MS Park HB Lee CAPD in Korea Med Prog 18 1996 7 9
4. Korean Society of Nephrology Renal replacement therapy in Korea: Registry data Korean J Nephrol 15 1996 S1 S7 suppl
5. J Dobbie Surgical peritonitis: Its relevance to the pathogenesis of peritonitis in CAPD Perit Dial Bull 8 1986 241 248
6. JW Dobbie Morphology of the peritoneum in CAPD Blood Purif 7 1989 74 85
7. N Di Paolo U Buoncristani L Capotondo Phosphatidylcholine and peritoneal transport during peritoneal dialysis Nephron 44 1986 365 370
8. GR Grahame MG Torchia KA Dankewich Surface-active-material in peritoneal effluent of CAPD patients Perit Dial Bull 5 1985 109 114
9. C Ziegler M Torchia GR Grahame Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients Perit Dial Int 9 1989 47 49
10. J Dobbie Ultrastructural similarities between mesothelium and type 11 pneumocytes and their relevance to phospholipid surfactant production by the peritoneum Adv Perit Dial 4 1988 32 41
11. C Basbaum MJ Welsh Mucous secretion and ion transport in airways JF Murray JA Nadel Textbook of Respiratory Medicine 1994 Saunders Philadelphia, PA 323 344
12. RH Rubin RS Cotran NE Tolkoff-Rubin Urinary tract infection, pyelonephritis, and reflux nephropathy BM Brenner The Kidney 1996 Saunders Philadelphia, PA 1597 1654
13. J Parkkinen R Virkola TK Korhonen Identification of factors in human urine that inhibit the binding of Escherichia coli adhesions Infect Immun 56 1988 26232630
14. JW Dobbie Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uraemia and CAPD patients Adv Perit Dial 4 1988 3 12
15. JW Dobbie The peritoneal biopsy registry: A watch dog for peritoneal dialysis Semin Dial 5 1992 20 23
16. JW Dobbie Monitoring peritoneal histopathology in peritoneal dialysis: The role of biopsy registry Dial Transplant 18 1989 319 335
17. MK Cha SY Jin MS Park The pathogenesis of peritoneal fibrosis after experimental peritonitis in rats Perit Dial Int 15 1995 57 suppl 1, abstr
18. JW Dobbie I Henderson LS Wilson New evidence on the pathogenesis of sclerosing encapsulating peritonitis (SEP) obtained from serial biopsies Adv Perit Dial 3 1987 138 149
19. JW Dobbie New concepts in molecular biology and ultrastructural pathology of the peritoneum: Their significance for peritoneal dialysis Am J Kidney Dis 15 1990 97 109
20. MS Park HA Yi JS Lee Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions J Am Soc Neprol 7 1996 1226 abstr
21. L Gotloib P Bar-Sella A Shostak Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: Ultrastructural changes of reduplicated peritoneal basement membrane Perit Dial Bull 5 1985 212 215
22. N Di Paolo G Sacchi M De Mia Does dialysis modify the peritoneal structure G La Greca S Chiaromonte Peritoneal Dialysis 1985 Wichtig Editore Milan, Italy 11 24
23. N Di Paolo G Sacchi Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): An in vitro model for the study of diabetic microangiopathy Perit Dial Int 9 1989 41 45
24. M Brownlee A Cerami H Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 13151321
25. H Vlassara H Fuh Z Makita Exogeneous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications Proc Natl Acad Sci USA 89 1992 12043 12047
26. HB Lee MK Cha KI Song Pathogenic role of advanced glycosylation end-products in diabetic nephropathy Kidney Int 52 1997 860 865 suppl 60
27. M Nakayama H Kubo A Ogawa Immunohistochemical detection of advanced glycation end products (AGEs) in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 1996 182 186
28. KO Smitherman JE Peacock Jr Infectious emergencies in patients with diabetes mellitus Med Clin North Am 79 1995 53 77
29. L Leibovici Y Yehezkeli A Porter Influence of diabetes mellitus and glycemic control on the characteristics and outcome of common infections Diabet Med 13 1996 457 463
30. C Verger A Luger HL Moore Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury Kidney Int 23 1983 823 831
31. D Whitaker JM Papadimitrou M Walters The mesothelium: Its fibrinolytic properties J Pathol 136 1982 291299
32. JW Dobbie MK Jasan Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesion in CAPD Perit Dial Int 17 1997 121 124
33. MS Park MH Na SH Chung JS Jeon SD Hwang HB Lee Peritoneal synthesis of type I and III procollagens and peritoneal membrane function in long-term CAPD patients Perit Dial Int 1998 18 (Supple): in press
34. P Joffe LT Jensen I Type CAPD III procollagens in Markers of peritoneal fibrosis Adv Perit Dial 7 1991 158160
35. MWJA Fieren Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis Blood Purif 14 1996 179187
36. N Topley JD Williams Effect of peritoneal dialysis on cytokine production by peritoneal cells Blood Purif 14 1996 188 197
37. N Topley JD Williams Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity Kidney Int 46 1994 S71 S78 suppl 48
38. CJ Holmes Peritoneal host defense mechanisms in peritoneal dialysis Kidney Int 46 1994 S58 S70 suppl 48
39. N Topley T Liberek A Davenport Activation of inflammation and leukocyte recruitment into the peritoneal cavity Kidney Int 50 1996 S17 S21 suppl 56
40. J Rubin Comments on dialysis solution, antibiotic transport, poisoning, and novel uses of peritoneal dialysis KD Nolph Peritoneal Dialysi 3rd ed 1989 Kluwer Boston, MA 199 229
41. AP Wieslander PTT Kjellstrand B Rippe Heat sterilzation of glucose-containing fluid for peritoneal dialysis: Biological consequences of chemical alterations Perit Dial Int 15 1995 S52 S60 suppl 1
42. HM Alobaidi GA Coles M Davies Host defense in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocytic function Nephrol Dial Transplant 1 1986 16 21
43. N Topley R Mackenzie MM Petersen In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid Nephrol Dial Transplant 6 1991 574 581
44. AK Duwe SI Vas JW Weatherhead Effect of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bacterial activity in vitro Infect Immun 33 1981 130 135
45. H Ha MS Park HB Lee High glucose induced human mesothelial cell synthesis of monocyte chemoattractant protein-1 is mediated by proteinase kinase-C Perit Dial Int 1998 in press
46. A Breborowicz H Rodela DG Oreopoulos Toxicity of osmotic solutes on human mesothelial cells in vitro Kidney Int 41 1992 1280 1285
47. T Liberek N Topley C Mistry Cell function and viability in glucose polymer dialysis fluids Perit Dial Int 13 1993 104 111
48. T Liberek N Topley A Jorres Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration J Am Soc Nephrol 3 1993 15081515
49. A Jorres D Jorres N Topley Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions Nephrol Dial Transplant 6 1991 495 501
50. A Breborowicz L Martis DG Oreopoulos In vitro influence of lactate on function of peritoneal fibroblasts Adv Perit Dial 10 1994 225 229
51. CB Nilsson-Thorell N Muscalu AHG Andren Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes Perit Dial Int 13 1993 208 213
52. AP Wieslander MK Nordin PTT Kjellstrand Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L929 Kidney Int 40 1991 77 79
53. VF Garry L Oatman R Pleus Formaldehyde in the home; some environmental disease perspectives Minn Med 63 1980 107 111
54. SJ Mcgregor JH Brock BJ Briggs Longitudinal study of peritoneal defense mechanisms in patients on continuous peritoneal dialysis (CAPD) Perit Dial Int 9 1989 115 119
55. WF Keane CM Comty HA Verbrugh Opsonic deficiency of peritoneal dialysis effluent in continuous peritoneal dialysis Kidney Int 25 1984 539 543
56. JC Davin AH Bouts RT Krediet IgG glycation and function during continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 12 1997 310 314
57. SJ McGregor N Topley A Jorres Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: Maturity, cytokine synthesis and arachidonic acid metabolism Kidney Int 49 1996 525533